Key Takeaways
- • Private equity ownership of U.S. substance use disorder (SUD) treatment facilities has expanded significantly, with PE firms controlling 7.1% of all SUD facilities nationally (1,152 of 16,174), with regional concentrations reaching 26.5% in Colorado.
- • A University of Arkansas for Medical Sciences and RAND Corporation study examining PE acquisitions of nonprofit and government-run SUD treatment facilities between 2019 and 2024 found that median income level was the only demographic characteristic associated with acquisition patterns, suggesting PE targets lower-income communities.
- • Post-acquisition operational changes include a 22% increase in patient load and a 19% increase in buprenorphine prescriptions, with research indicating PE firms increase participation in public insurance programs to expand revenue sources at acquired facilities.
- • National private equity involvement in healthcare broadly increased twentyfold between 2000 and 2018, with a 2025 Health Policy journal article associating PE acquisition of healthcare facilities with worsened or mixed patient health outcomes, raising concerns about SUD treatment quality and access.
- • SUD treatment facilities have become attractive acquisition targets for private equity due to increased demand for treatment services, expanded health insurance coverage, and reliable reimbursement streams from both public and private payers.
Summary
Private equity firms have significantly expanded their footprint in the substance use disorder treatment sector, controlling 7.1% of all SUD facilities nationally—approximately 1,152 of 16,174 facilities—with ownership concentration varying substantially by geography. Colorado represents a high-penetration market with PE ownership reaching 26.5% of mental health facilities, signaling regional market consolidation patterns. This expansion reflects broader trends in private equity healthcare investment, which increased twentyfold between 2000 and 2018 nationally.
A recent study by researchers at the University of Arkansas for Medical Sciences and the RAND Corporation examined whether private equity acquisitions of nonprofit and government-operated SUD treatment facilities concentrate in underrepresented and under-resourced communities. Using data from the Mental Health and Addiction Treatment Tracking Repository, the researchers identified facilities acquired by private equity between 2019 and 2024 and cross-referenced them with U.S. Census Bureau demographic data. Among the characteristics analyzed—including rurality, health insurance coverage rates, racial composition, and median income—median income emerged as the sole demographic factor statistically associated with PE acquisition patterns, suggesting a strategic focus on lower-income communities.
Post-acquisition operational metrics reveal significant changes in facility operations. Facilities increased patient loads by 22% and buprenorphine prescriptions by 19% following private equity takeover, according to research cited in 2025 publications. PE firms have actively restructured insurance participation strategies, with evidence suggesting acquisitions increase reliance on public insurance programs to diversify and expand revenue sources. These facilities have become attractive targets due to growing demand for SUD treatment, expanded insurance coverage eligibility, and predictable reimbursement streams.
However, academic literature raises concerns about these ownership transitions. A 2025 Health Policy journal article linked private equity acquisition of healthcare facilities to worsened or mixed health outcomes for patients. This finding carries particular weight for the SUD treatment sector, where patient outcomes directly reflect treatment quality and access to evidence-based therapies. The concentration of acquisitions in lower-income communities, combined with restructuring toward higher patient volumes and insurance optimization, suggests tension between financial returns and clinical outcomes in a sector serving vulnerable populations.
A recent study by researchers at the University of Arkansas for Medical Sciences and the RAND Corporation examined whether private equity acquisitions of nonprofit and government-operated SUD treatment facilities concentrate in underrepresented and under-resourced communities. Using data from the Mental Health and Addiction Treatment Tracking Repository, the researchers identified facilities acquired by private equity between 2019 and 2024 and cross-referenced them with U.S. Census Bureau demographic data. Among the characteristics analyzed—including rurality, health insurance coverage rates, racial composition, and median income—median income emerged as the sole demographic factor statistically associated with PE acquisition patterns, suggesting a strategic focus on lower-income communities.
Post-acquisition operational metrics reveal significant changes in facility operations. Facilities increased patient loads by 22% and buprenorphine prescriptions by 19% following private equity takeover, according to research cited in 2025 publications. PE firms have actively restructured insurance participation strategies, with evidence suggesting acquisitions increase reliance on public insurance programs to diversify and expand revenue sources. These facilities have become attractive targets due to growing demand for SUD treatment, expanded insurance coverage eligibility, and predictable reimbursement streams.
However, academic literature raises concerns about these ownership transitions. A 2025 Health Policy journal article linked private equity acquisition of healthcare facilities to worsened or mixed health outcomes for patients. This finding carries particular weight for the SUD treatment sector, where patient outcomes directly reflect treatment quality and access to evidence-based therapies. The concentration of acquisitions in lower-income communities, combined with restructuring toward higher patient volumes and insurance optimization, suggests tension between financial returns and clinical outcomes in a sector serving vulnerable populations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.